Skip to content

Happy Long Tab(5mg) once daily in the management of erectile dysfunction in Diabetes’s patients

Happy Long Tab(5mg) once daily in the management of erectile dysfunction in Diabetes’s patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007552
Enrollment
30
Registered
2022-07-25
Start date
2018-09-05
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Soon Chun Hyang University Hospital Seoul
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: - a man over twenty years of age - Patients with erectile dysfunction with a history of diagnosis and treatment of diabetes with an HbA1C of 6.5 months or more - Subjects of the study who voluntarily participated in the clinical trial and the preparation of written consent forms

Exclusion criteria

Exclusion criteria: 1) Patients with myocardial infarction within the last 90 days. 2) Patients with unstable angina or angina during sexual intercourse 3) Patients with New York Heart Association Class 2 or higher heart failure in the last 6 months 4) Patients who had a stroke within the last six months. 5) Patients with hereditary degenerative retinopathy, including pigmented retinitis 6) Patients with hypersensitivity to PDE5 inhibitors. 7) Patients taking other PDE5 inhibitors. 8) Patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose absorption disorder. 9) a patient with anterior ischemic optic neurosis 10) Patients administering the GC stimulant (Guanylate Cycle Stimulus).

Design outcomes

Primary

MeasureTime frame
Nailfold capillary microscopy

Secondary

MeasureTime frame
IIEF-5 Before and After Questionnaire

Countries

Korea, Republic of

Contacts

Public ContactHwayeon Sun

Soon Chun Hyang University Hospital Seoul

ssunhwayeon@gmail.com+82-2-709-9158

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026